Annissa J. Huhn

Annissa J. Huhn

Auto-generated profile, based on publicly available information

Annissa J. Huhn

Department of Pediatric Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA; Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2016 in Cell Chemical Biology
Verified
Journal Article
Closed access
AHAnnissa J. Huhn
Annissa J. Huhn
RGRachel M. Guerra
Rachel M. Guerra
EHEdward P. Harvey
Edward P. Harvey
GBGregory H. Bird
Gregory H. Bird
LWLoren D. Walensky
Loren D. Walensky

23 April 2020 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Closed access
JWJonathan E. Wilson
Jonathan E. Wilson
GPGaurav Patel
Gaurav Patel
CPChirag Patel
Chirag Patel
FBFrancois Brucelle
Francois Brucelle
AHAnnissa Huhn
Annissa Huhn
JLJulian R. Levell
Julian R. Levell

9 May 2016 in Nature Structural & Molecular Biology
Verified
Journal Article
Open access
PDF file
SLSusan Lee
Susan Lee
TWThomas E Wales
Thomas E Wales
SESilvia Escudero
Silvia Escudero
DCDaniel T Cohen
Daniel T Cohen
JLJames Luccarelli
James Luccarelli
LWLoren D Walensky
Loren D Walensky
MCL-1 is an antiapoptotic BCL-2 family protein that has emerged as a major pathogenic factor in human cancer. Like BCL-2, MCL-1 bears a surface groove whose function is to sequester the BH3 killer domains of proapoptotic BCL-2 family members, a mechanism harnessed by cancer cells to establish formidable apoptotic blockades. Although drugging the BH3-binding groove has been achieved for BCL-2, translating this approach to MCL-1 has been challenging. Here, we report an alternative mechanism for MCL-1 inhibition by small-molecule covalent modification of C286 at a new interaction site distant from the BH3-binding groove. Our structure–function analyses revealed that the BH3 binding capacity of MCL-1 and its suppression of BAX are impaired by molecular engagement, a phenomenon recapitulated by C286W mutagenic mimicry in vitro and in mouse cells. Thus, we characterize an allosteric mechanism for disrupting the antiapoptotic BH3 binding activity of MCL-1, informing a new strategy for disarming MCL-1 in cancer.

2 July 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LTLia Tesfay
Lia Tesfay
AHAnnissa J. Huhn
Annissa J. Huhn
HHHeather Hatcher
Heather Hatcher
FTFrank M. Torti
Frank M. Torti
STSuzy Torti
Suzy Torti
Angiogenesis is tightly regulated through complex crosstalk between pro- and anti-angiogenic signals. High molecular weight kininogen (HK) is an endogenous protein that is proteolytically cleaved in plasma and on endothelial cell surfaces to HKa, an anti-angiogenic protein. Ferritin binds to HKa and blocks its anti-angiogenic activity. Here, we explore mechanisms underlying the cytoprotective effect of ferritin in endothelial cells exposed to HKa. We observe that ferritin promotes adhesion and survival of HKa-treated cells and restores key survival and adhesion signaling pathways mediated by Erk, Akt, FAK and paxillin. We further elucidate structural motifs of both HKa and ferritin that are required for effects on endothelial cells. We identify an histidine-glycine-lysine (HGK) -rich antiproliferative region within domain 5 of HK as the target of ferritin, and demonstrate that both ferritin subunits of the H and L type regulate HKa activity. We further demonstrate that ferritin reduces binding of HKa to endothelial cells and restores the association of uPAR with α5β1 integrin. We propose that ferritin blocks the anti-angiogenic activity of HKa by reducing binding of HKa to UPAR and interfering with anti-adhesive and anti-proliferative signaling of HKa.

21 July 2015 in ACS Chemical Biology
Verified
Journal Article
Closed access
AEAmanda L. Edwards
Amanda L. Edwards
FWFranziska Wachter
Franziska Wachter
MLMargaret Lammert
Margaret Lammert
AHAnnissa J. Huhn
Annissa J. Huhn
JLJames Luccarelli
James Luccarelli
LWLoren D. Walensky
Loren D. Walensky

1 June 2020 in Cell Chemical Biology
Verified
Journal Article
Closed access
EHEdward P. Harvey
Edward P. Harvey
ZHZachary J. Hauseman
Zachary J. Hauseman
DCDaniel T. Cohen
Daniel T. Cohen
TRT. Justin Rettenmaier
T. Justin Rettenmaier
SLSusan Lee
Susan Lee
LWLoren D. Walensky
Loren D. Walensky